Tapewire

Nasdaq · USD

NNBR

NN INC

Export transactions ↓
Tapewire entity
6041
SEC CIK
0000918541
Parsed reports
308

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 2026027
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2018 Filed Mar 16, 2018 23:37 UTC
Floyd DavidDirector
GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007807 · doc4.xml · nonDerivative · entry 1

Floyd David · CIK 0001564203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,050

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:36 UTC
Heiter Matthew S.Senior VP and General Counsel
GrantPerformance Rights · Derivative 3,908 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007806 · doc4.xml · derivative · entry 2

Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,908

Underlying: Common Stock · 3,908 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F3 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

F3 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:36 UTC
Heiter Matthew S.Senior VP and General Counsel
GrantCommon Stock 3,908 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007806 · doc4.xml · nonDerivative · entry 1

Heiter Matthew S. · CIK 0001647819 · Senior VP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,086

F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:34 UTC GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007803 · doc4.xml · nonDerivative · entry 1

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,805

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:31 UTC
Holder Richard DDirector · President & CEO
GrantPerformance Rights · Derivative 30,549 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007800 · doc4.xml · derivative · entry 2

Holder Richard D · CIK 0001360591 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,549

Underlying: Common Stock · 30,549 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F3 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

F3 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:31 UTC
Holder Richard DDirector · President & CEO
GrantCommon Stock 30,549 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007800 · doc4.xml · nonDerivative · entry 1

Holder Richard D · CIK 0001360591 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,814

F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:30 UTC GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007799 · doc4.xml · nonDerivative · entry 1

Brunner Robert E · CIK 0001380372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,605

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:30 UTC
PUGH DAVID LDirector
GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007798 · doc4.xml · nonDerivative · entry 1

PUGH DAVID L · CIK 0001208344 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,905

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:25 UTC GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007793 · doc4.xml · nonDerivative · entry 1

DRIES WILLIAM · CIK 0001176412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,905

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:22 UTC
Atkinson James RobertEVP, Life Sciences
GrantPerformance Rights · Derivative 3,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007789 · doc4.xml · derivative · entry 2

Atkinson James Robert · CIK 0001674150 · EVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F3 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

F3 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:22 UTC
Atkinson James RobertEVP, Life Sciences
GrantCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007789 · doc4.xml · nonDerivative · entry 1

Atkinson James Robert · CIK 0001674150 · EVP, Life Sciences

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,741

F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:23 UTC GrantCommon Stock 4,073 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007791 · doc4.xml · nonDerivative · entry 1

Smith Carey A. · CIK 0001707270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,331

F1 · price: Shares are restricted stock and vest on March 14, 2019.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:21 UTC
Veltman Warren AEVP, Mobile Solutions
GrantPerformance Rights · Derivative 4,149 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007788 · doc4.xml · derivative · entry 2

Veltman Warren A · CIK 0001618759 · EVP, Mobile Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,149

Underlying: Common Stock · 4,149 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F3 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

F3 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2018 and ending December 31, 2020. The performance rights will vest on December 31, 2020 subject to the reporting person's continuous employment through December 31, 2020 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2020 expire automatically.

Read SEC document
March 14, 2018 Filed Mar 16, 2018 23:21 UTC
Veltman Warren AEVP, Mobile Solutions
GrantCommon Stock 4,149 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-007788 · doc4.xml · nonDerivative · entry 1

Veltman Warren A · CIK 0001618759 · EVP, Mobile Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,577

F1 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 14, 2019.

Read SEC document
December 01, 2017 Filed Dec 5, 2017 21:05 UTC
Floyd DavidDirector
PurchaseCommon Stock 1,865 $26.98 $50,317.70
Disclosure

SEC source: 0000899243-17-027948 · doc4.xml · nonDerivative · entry 1

Floyd David · CIK 0001564203 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family LP

Disclosed balance after: 3,323

F1 · ownership.nature: Shares are held by the David and Lisa Floyd Family Limited Partnership of which the reporting person and his wife are the sole general partners and sole limited partners.

Read SEC document
October 25, 2017 Filed Oct 27, 2017 20:05 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 2,000 $0.00 Strike: $8.86 $0.00
Disclosure

SEC source: 0000899243-17-024811 · doc4.xml · derivative · entry 3

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 2,000 shares

Expires 2022-03-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 25, 2017 Filed Oct 27, 2017 20:05 UTC SaleCommon Stock 2,000 $32.00 $64,000.00
Disclosure

SEC source: 0000899243-17-024811 · doc4.xml · nonDerivative · entry 2

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,381

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
October 25, 2017 Filed Oct 27, 2017 20:05 UTC Exercise / conversionCommon Stock 2,000 $8.86 $17,720.00
Disclosure

SEC source: 0000899243-17-024811 · doc4.xml · nonDerivative · entry 1

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,381

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
October 20, 2017 Filed Nov 22, 2017 21:07 UTC
Qualters Christopher J.VP, Chief Commercial Officer
Tax withholdingCommon Stock 316 $30.70 $9,701.20
Disclosure

SEC source: 0000899243-17-027284 · doc4.xml · nonDerivative · entry 1

Qualters Christopher J. · CIK 0001707268 · VP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,747

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 20, 2017 Filed Nov 22, 2017 21:05 UTC
Veltman Warren ASVP/GM Autocam Precision Comp.
Tax withholdingCommon Stock 483 $30.70 $14,828.10
Disclosure

SEC source: 0000899243-17-027281 · doc4.xml · nonDerivative · entry 1

Veltman Warren A · CIK 0001618759 · SVP/GM Autocam Precision Comp.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,428

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 19, 2017 Filed Sep 19, 2017 20:05 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 2,000 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · derivative · entry 6

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 19, 2017 Filed Sep 19, 2017 20:05 UTC SaleCommon Stock 2,000 $27.75 $55,500.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · nonDerivative · entry 4

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,732

Read SEC document
September 19, 2017 Filed Sep 19, 2017 20:05 UTC Exercise / conversionCommon Stock 2,000 $9.36 $18,720.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · nonDerivative · entry 3

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
September 18, 2017 Filed Sep 18, 2017 20:05 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 1,500 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · derivative · entry 6

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 18, 2017 Filed Sep 18, 2017 20:05 UTC SaleCommon Stock 1,500 $28.00 $42,000.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · nonDerivative · entry 4

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,381

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2017.

Read SEC document
September 18, 2017 Filed Sep 18, 2017 20:05 UTC Exercise / conversionCommon Stock 1,500 $9.36 $14,040.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · nonDerivative · entry 3

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
September 18, 2017 Filed Sep 19, 2017 20:05 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 1,000 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · derivative · entry 5

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 1,000 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 18, 2017 Filed Sep 19, 2017 20:05 UTC SaleCommon Stock 1,000 $27.85 $27,850.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · nonDerivative · entry 2

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,732

Read SEC document
September 18, 2017 Filed Sep 19, 2017 20:05 UTC Exercise / conversionCommon Stock 1,000 $9.36 $9,360.00
Disclosure

SEC source: 0000899243-17-022281 · doc4.xml · nonDerivative · entry 1

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
September 15, 2017 Filed Sep 15, 2017 21:13 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 3,000 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · derivative · entry 6

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2017 Filed Sep 15, 2017 21:13 UTC SaleCommon Stock 3,000 $27.25 $81,750.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · nonDerivative · entry 4

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,732

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.75, inclusive. The reporting person undertakes to provide to NN, Inc., any security holder of NN, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 15, 2017 Filed Sep 15, 2017 21:13 UTC Exercise / conversionCommon Stock 3,000 $9.36 $28,080.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · nonDerivative · entry 3

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
September 15, 2017 Filed Sep 18, 2017 20:05 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 4,500 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · derivative · entry 5

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 4,500 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2017 Filed Sep 18, 2017 20:05 UTC SaleCommon Stock 4,500 $27.17 $122,265.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · nonDerivative · entry 2

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,381

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2017.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.50, inclusive. The reporting person undertakes to provide to NN, Inc., any security holder of NN, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 15, 2017 Filed Sep 18, 2017 20:05 UTC Exercise / conversionCommon Stock 4,500 $9.36 $42,120.00
Disclosure

SEC source: 0000899243-17-022203 · doc4.xml · nonDerivative · entry 1

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 21:13 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 2,000 $0.00 Strike: $9.36 $0.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · derivative · entry 5

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 2,000 shares

Expires 2018-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 21:13 UTC SaleCommon Stock 2,000 $26.82 $53,640.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · nonDerivative · entry 2

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,732

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.77 to $26.88, inclusive. The reporting person undertakes to provide to NN, Inc., any security holder of NN, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 14, 2017 Filed Sep 15, 2017 21:13 UTC Exercise / conversionCommon Stock 2,000 $9.36 $18,720.00
Disclosure

SEC source: 0000899243-17-022155 · doc4.xml · nonDerivative · entry 1

WARSHAW STEVEN T · CIK 0001196823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Corresponds to option exercise price.

Read SEC document
May 19, 2017 Filed May 23, 2017 20:07 UTC GrantCommon Stock 2,258 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-014124 · doc4.xml · nonDerivative · entry 1

Smith Carey A. · CIK 0001707270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,258

F1 · price: Shares are restricted stock and vest on May 18, 2018.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:06 UTC
WIDDERS JAMES R.SVP/Integration & Corp.
Tax withholdingCommon Stock 238 $27.60 $6,568.80
Disclosure

SEC source: 0000899243-17-011416 · doc4.xml · nonDerivative · entry 1

WIDDERS JAMES R. · CIK 0001511320 · SVP/Integration & Corp.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,295

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:06 UTC Tax withholdingCommon Stock 128 $27.60 $3,532.80
Disclosure

SEC source: 0000899243-17-011417 · doc4.xml · nonDerivative · entry 1

BURWELL THOMAS C. Jr. · CIK 0001529081 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,381

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:05 UTC
MANZAGOL L JEFFREYSVP/GM-Precision Bearings Comp
Tax withholdingCommon Stock 288 $27.60 $7,948.80
Disclosure

SEC source: 0000899243-17-011414 · doc4.xml · nonDerivative · entry 1

MANZAGOL L JEFFREY · CIK 0001624139 · SVP/GM-Precision Bearings Comp

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,767

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:05 UTC Tax withholdingCommon Stock 56 $27.60 $1,545.60
Disclosure

SEC source: 0000899243-17-011413 · doc4.xml · nonDerivative · entry 1

Atkinson James Robert · CIK 0001674150 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,741

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:05 UTC
Holder Richard DDirector · President & CEO
Tax withholdingCommon Stock 1,222 $27.60 $33,727.20
Disclosure

SEC source: 0000899243-17-011412 · doc4.xml · nonDerivative · entry 1

Holder Richard D · CIK 0001360591 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,265

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
April 28, 2017 Filed May 2, 2017 20:05 UTC
Veltman Warren ASVP/GM Autocam Precision Comp.
Tax withholdingCommon Stock 288 $27.60 $7,948.80
Disclosure

SEC source: 0000899243-17-011411 · doc4.xml · nonDerivative · entry 1

Veltman Warren A · CIK 0001618759 · SVP/GM Autocam Precision Comp.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,911

F1 · shares: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 00:29 UTC
Manzi JohnSVP/GM-Precision Eng. Products
GrantPerformance Rights · Derivative 3,355 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008253 · doc4.xml · derivative · entry 3

Manzi John · CIK 0001656665 · SVP/GM-Precision Eng. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,355

Underlying: Common Stock · 3,355 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F4 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2017 and ending December 31, 2019. The performance rights will vest on December 31, 2019 subject to the reporting person's continuous employment through December 31, 2019 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2019 expire automatically.

F4 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2017 and ending December 31, 2019. The performance rights will vest on December 31, 2019 subject to the reporting person's continuous employment through December 31, 2019 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2019 expire automatically.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 00:29 UTC
Manzi JohnSVP/GM-Precision Eng. Products
GrantCommon Stock 3,828 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008253 · doc4.xml · nonDerivative · entry 2

Manzi John · CIK 0001656665 · SVP/GM-Precision Eng. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,152

F2 · kind: Shares are restricted stock and vest in three equal annual installments beginning on March 17, 2018.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 00:35 UTC
PUGH DAVID LDirector
GrantCommon Stock 4,132 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008261 · doc4.xml · nonDerivative · entry 1

PUGH DAVID L · CIK 0001208344 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,832

F1 · price: Shares are restricted stock and vest on March 17, 2018.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 00:32 UTC GrantPerformance Rights · Derivative 1,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-008259 · doc4.xml · derivative · entry 5

Atkinson James Robert · CIK 0001674150 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,328

Underlying: Common Stock · 1,328 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of common stock of NN, Inc. (the "Issuer").

F5 · derivative.exercise_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2017 and ending December 31, 2019. The performance rights will vest on December 31, 2019 subject to the reporting person's continuous employment through December 31, 2019 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2019 expire automatically.

F5 · derivative.expiration_date: The vesting of the performance rights is based on the relative total shareholder return ("TSR") of the Issuer, as compared to the TSR of the S&P SmallCap 600 Index over the period beginning on January 1, 2017 and ending December 31, 2019. The performance rights will vest on December 31, 2019 subject to the reporting person's continuous employment through December 31, 2019 and subject to certain conditions as set forth in the Issuer's 2016 Omnibus Incentive Plan. Performance rights granted represent the right to receive the target shares, and actual performance rights earned may be between 50% and 150% of the target shares. Performance rights that do not vest on December 31, 2019 expire automatically.

Read SEC document
March 17, 2017 Filed Mar 21, 2017 00:32 UTC GrantStock Options (Right to Buy) · Derivative 13,200 $0.00 Strike: $24.20 $0.00
Disclosure

SEC source: 0000899243-17-008259 · doc4.xml · derivative · entry 4

Atkinson James Robert · CIK 0001674150 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,200

Underlying: Common Stock · 13,200 shares

Expires 2027-03-17

F3 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.